Effect of an olive-oil bioactive extract on basal TEER (A) and TNF-α induced decrease in TEER (B) <i>in vitro</i>. by Martin Liehr (3863431)

Maximum concentrations (ng/L) of 88 pharmaceuticals detected at least once (in order of decreasing number of detections across all regions and samples) in water samples from wadeab... by Paul M. Bradley (523469)

<i>Ang1</i>-deficient mice develop significantly fewer tumors compared to WT mice following AOM-DSS. by Alexander Hu (14755811)

Interfacial Adhesion Forces of Hydrate Particles in the Presence of Hydrate Inhibitors by Wenjuan Zhang (234517)

Subjects:

Interfacial Adhesion Forces of Hydrate Particles in the Presence of Hydrate Inhibitors by Wenjuan Zhang (234517)

Subjects:

Main components of bauxite and BCFD (wt.%). by Nian Liu (29935)

“…Results indicated that the optimal conditions for mixed desilication are BCFD/bauxite mass ratio of 1:6, desilication temperature of 95°C, desilication time of 30 min, alkali concentration of 110 g/L, and liquid-solid ratio of 10:1, achieving a desilication rate of 60.90%. The Al-Si ratio (A/S) of the concentrate increases from 5.33 to 11.72, meeting the requirements for brown corundum smelting raw materials. …”

Flow cytometry analysis of the changes in macrophage proportions in iNOS-KO and WT control rats. by Jia Shen (1828945)

CLE mutation decreases H3K27me3 levels on the viral IR. by Jacqueline Williams (3493745)

Thymus regeneration promotes naïve T-cell recovery in iMycTg aging-E mice and a partial decrease in Treg frequencies. by Abigail Morales-Sánchez (21799582)

TNF-α inhibited A549 cell viability, increased paracellular permeability, HIF-1α expression and decreased VASP expression. by Mengjie Tang (602523)

Modeled structures of C1-RhoGAP domain of WT PARG1, I845V and T622M mutants. by Zen Kouchi (14898435)

Activity of WT and GAD65-KO and blood EtOH concentration. by Wataru Matsunaga (3452621)

Changes in blood pressure before, during and after regadenoson (RA) infusion. by Joseph Rabin (7399436)

Subjects:

Diagram showing some of the factors that mediate cytokin storm following infection with COVID-19. by Joseph Rabin (7399436)

Subjects:

Antibodies used for flow cytometry experiments. by Joseph Rabin (7399436)

Subjects:

Changes of plasma proinflammatory cytokines/chemokines during and after RA infusion. by Joseph Rabin (7399436)

Subjects:

Demographics of the COVID-19 patients who received regadenoson treatment. by Joseph Rabin (7399436)

Subjects:

Subject flow diagram. by Joseph Rabin (7399436)

Subjects:

Effects of regadenoson (RA) infusion on oxygen saturation and C-reactive protein (CRP) levels in plasma of COVID-19 patients. by Joseph Rabin (7399436)

Subjects:

Distinct effects on calcium channel activation of <i>CACNA1I</i> disease-associated amino acid substitutions A398E/V and M1425V/I. by Yousra El Ghaleb (22075892)

Subjects: